Postdiagnosis Isoflavone and Lignan Intake in Newly Diagnosed Breast Cancer Patients: Cross-Sectional Survey Shows Considerable Intake from Previously Unassessed High-Lignan Foods | Zendy

Beatrice A. Boucher | Zendy; Susitha Wanigaratne | Zendy; Shelley A. Harris | Zendy; Michelle Cotterchio | Zendy

Open Access

Postdiagnosis Isoflavone and Lignan Intake in Newly Diagnosed Breast Cancer Patients: Cross-Sectional Survey Shows Considerable Intake from Previously Unassessed High-Lignan Foods

Author(s) -

Beatrice A. Boucher,

Susitha Wanigaratne,

Shelley A. Harris,

Michelle Cotterchio

Publication year - 2017

Publication title -

current developments in nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.904

H-Index - 14

ISSN - 2475-2991

DOI - 10.3945/cdn.117.002063

Subject(s) - lignan , medicine , breast cancer , cross sectional study , cancer , chemistry , pathology , stereochemistry

Postdiagnosis lignan intakes from 3 high-content foods may be considerable among newly diagnosed breast cancer patients, yet they have been unassessed in previous prognostic studies. The inclusion of these foods in dietary assessment methods may improve future intake estimates and the distributions on which breast cancer survival analyses are based.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research